Agilent Technologies Inc

Diagnostics & Research

Prices are adjusted according to historical splits.

Agilent Technologies Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$41.50 billion
Book Value:
Revenue TTM:
$6.93 billion
Operating Margin TTM:
Gross Profit TTM:
$3.72 billion
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Agilent Technologies Inc had its IPO on 1999-11-18 under the ticker symbol A.

The company operates in the Healthcare sector and Diagnostics & Research industry. Agilent Technologies Inc has a staff strength of 18,000 employees.

Stock update

Shares of Agilent Technologies Inc opened at $117.77 at the start of the last trading session i.e. 2023-06-02.

The stocks traded within a range of $116.02 - $118.41, and closed at $118.22.

This is a +1.69% increase from the previous day's closing price.

A total volume of 3,203,965 shares were traded at the close of the day’s session.

In the last one week, shares of Agilent Technologies Inc have slipped by -2.29%.

Agilent Technologies Inc's Key Ratios

Agilent Technologies Inc has a market cap of $41.50 billion, indicating a price to book ratio of 8.6347 and a price to sales ratio of 6.4988.

In the last 12-months Agilent Technologies Inc’s revenue was $6.93 billion with a gross profit of $3.72 billion and an EBITDA of $2.02 billion. The EBITDA ratio measures Agilent Technologies Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Agilent Technologies Inc’s operating margin was 24.78% while its return on assets stood at 10.1% with a return of equity of 24.58%.

In Q0.33333333333333, Agilent Technologies Inc’s quarterly earnings growth was a positive 27.9% while revenue growth was a positive 4.9%.

Agilent Technologies Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $4.44 per share while it has a forward price to earnings multiple of 26.9542 and a PEG multiple of 2.3596. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Agilent Technologies Inc’s profitability.

Agilent Technologies Inc stock is trading at a EV to sales ratio of 6.9195 and a EV to EBITDA ratio of 24.874. Its price to sales ratio in the trailing 12-months stood at 6.4988.

Agilent Technologies Inc stock pays annual dividends of $0.855 per share, indicating a yield of 0.63% and a payout ratio of 16.2%.

Balance sheet and cash flow metrics

Total Assets
$10.92 billion
Total Liabilities
$1.94 billion
Operating Cash Flow
Capital Expenditure
$76 million
Dividend Payout Ratio

Agilent Technologies Inc ended 2023 with $10.92 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $10.92 billion while shareholder equity stood at $5.61 billion.

Agilent Technologies Inc ended 2023 with $0 in deferred long-term liabilities, $1.94 billion in other current liabilities, 3000000.00 in common stock, $541.00 million in retained earnings and $3.98 billion in goodwill. Its cash balance stood at $1.25 billion and cash and short-term investments were $1.25 billion. The company’s total short-term debt was $238,000,000 while long-term debt stood at $2.73 billion.

Agilent Technologies Inc’s total current assets stands at $4.08 billion while long-term investments were $188.00 million and short-term investments were $0. Its net receivables were $1.46 billion compared to accounts payable of $540.00 million and inventory worth $1.11 billion.

In 2023, Agilent Technologies Inc's operating cash flow was $-104000000.00 while its capital expenditure stood at $76 million.

Comparatively, Agilent Technologies Inc paid $0.16 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Agilent Technologies Inc stock is currently trading at $118.22 per share. It touched a 52-week high of $160.0263 and a 52-week low of $160.0263. Analysts tracking the stock have a 12-month average target price of $163.71.

Its 50-day moving average was $131.73 and 200-day moving average was $139.12 The short ratio stood at 2.68 indicating a short percent outstanding of 0%.

Around 21.8% of the company’s stock are held by insiders while 9059.1% are held by institutions.

Frequently Asked Questions About Agilent Technologies Inc

The stock symbol (also called stock or share ticker) of Agilent Technologies Inc is A

The IPO of Agilent Technologies Inc took place on 1999-11-18

Similar Industry Stocks (Diagnostics & Research)

Last Price

Most Active

Last Price
Zomato Limited (ZOMATO)
Tesla Inc (TSLA)
Yes Bank Limited (YESBANK)

Top Gainers

Last Price
AEye Inc (LIDRW)

Top Losers

Last Price


Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer’s representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquar


5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051